StonvexLoading…
StonvexStonvexStonvexCore line items from RDY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $3.81B | $3.35B | $2.99B | $2.83B |
Operating Income | $842.00M | $813.00M | $695.00M | $389.00M |
Net Income | $671.00M | $668.00M | $548.00M | $311.00M |
EPS (Diluted) | $0.79 | $4.01 | $3.30 | $1.87 |
Total Assets | $5.77B | $4.65B | $3.92B | $3.86B |
Total Liabilities | $1.82B | $1.28B | $1.11B | $1.35B |
Cash & Equivalents | $172.00M | $85.00M | $70.00M | $196.00M |
Free Cash Flow OCF − CapEx | $223.00M | $348.00M | $578.00M | $177.00M |
Shares Outstanding | 832.64M | 830.78M | 829.79M | 165.73M |